A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorAsian Institute of Gastroenterology, India

About this trial

To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.

Eligibility criteria

Qualifiers

Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both).

Ability to provide written informed consent.

Disqualifiers

Known gastric malignancy.

Prior gastric surgery (excluding H. pylori eradication).

Contraindications to endoscopy or biopsy.

Known hereditary gastric cancer syndromes.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed